ADial Pharmaceuticals Announces Publication of Study on AD04 for the Treatment of Patients With Alcohol Use Disorder

Published: Aug 13, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CHARLOTTESVILLE, Va., Aug. 12, 2013 (GLOBE NEWSWIRE) -- ADial Pharmaceuticals (ADial) announced today that the prestigious American Journal of Psychiatry ("AJP") has published a seminal article on the treatment of alcohol addiction using ADial's drug, AD04, in patients with selected genotypes. The study is a major step toward developing a more personalized and effective approach to the treatment of alcohol use disorder based on a patient's genetic makeup. The article is currently available through the online journal AJP in Advance.

Help employers find you! Check out all the jobs and post your resume.

Back to news